                         SEQUENCE LISTING

<110>  The Board of Regents of The University of Texas System
 
<120>  LGR4 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

<130>  UTFH.P0323WO

<140>  Unknown
<141>  2016-12-09

<150>  US 62/267,409
<151>  2015-12-15

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  117
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Asn Leu Ser Cys Lys Thr Ser Gly Tyr Thr Phe Ser Thr Ser 
            20                  25                  30          


Tyr Met Ser Trp Phe Lys Gln Ile Pro Gly Gln Thr Ile Glu Trp Val 
        35                  40                  45              


Gly Leu Ile Tyr Val Gly Ala Gly Gly Pro Thr Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Ser Leu Thr Val Asp Thr Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Asp Leu Ser Ser Leu Thr Ala Glu Asp Ser Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Val Arg Gly Tyr Ala Met Asp Ala Trp Gly Gln Gly Thr Ser 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  2
<211>  351
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
caggtccagc tgcagcaatc tggggctgag ttggtaaagc ctggtgcttc agtgaatttg       60

tcctgcaaga cttctggtta caccttcagc actagctaca tgagttggtt caagcagatt      120

cctggacaga ctattgagtg ggttggactg atttatgttg gagctggtgg tcctacctat      180

aatcagaagt tcaagggcaa ggcctcactt actgtcgaca catcttccag cacagcgtac      240

atggatctca gcagcctgac agctgaggac tctgcagtct atttttgtgc aagggttcgg      300

ggctatgcta tggatgcctg gggtcaagga acttcagtca ccgtctcctc a               351


<210>  3
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  3

Gly Tyr Thr Phe Ser Thr Ser Tyr 
1               5               


<210>  4
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Ile Tyr Val Gly Ala Gly Gly Pro 
1               5               


<210>  5
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Ala Arg Val Arg Gly Tyr Ala Met Asp Ala 
1               5                   10  


<210>  6
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  6

Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Glu Ser Val Ser Leu Ser Cys Arg Ala Ser Gln Asp Ile Ser Thr Ser 
            20                  25                  30          


Ile His Trp Tyr Gln Gln Lys Ser Asn Glu Ser Pro Arg Leu Leu Ile 
        35                  40                  45              


Lys Tyr Ala Ser Gln Ser Ile Ser Gly Ile Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Arg Val Glu Ser 
65                  70                  75                  80  


Glu Asp Phe Ser Val Tyr Tyr Cys Gln Gln Ser Tyr Ser Leu Pro Val 
                85                  90                  95      


Thr Phe Gly Ser Gly Thr Lys Leu Glu Leu Lys Arg 
            100                 105             


<210>  7
<211>  324
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
gacattgtgc tcacccagtc tccagccacc ctgtctgtga ctccaggaga gagtgtgagt       60

ctctcctgca gggccagtca ggatattagc actagcattc attggtatca gcaaaaatca      120

aatgagtctc caaggcttct catcaagtat gcttcccagt ccatctctgg aatcccctcc      180

aggttcagtg gaggtggatc agggacagat ttcactctca ctatcaacag agtcgaatct      240

gaagattttt cagtttatta ctgtcaacag agttacagct tgcccgtcac gttcggatct      300

gggaccaagc tggaactgaa acgg                                             324


<210>  8
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Gln Asp Ile Ser Thr Ser 
1               5       


<210>  9
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  9

Tyr Ala Ser 
1           


<210>  10
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  10

Gln Gln Ser Tyr Ser Leu Pro Val Thr 
1               5                   


<210>  11
<211>  119
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  11

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Leu Val Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Asn 
            20                  25                  30          


Phe Met His Trp Ile Lys Gln Gln Pro Gly Asn Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Tyr Pro Gly Asp Gly Asp Thr Asp Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Ile Gly Lys Ala Thr Leu Thr Ala Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys 
                85                  90                  95      


Ser Arg Ser Asn Ser Gly Tyr Asn Trp Phe Ala Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  12
<211>  357
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  12
caggttcagc tgcagcagtc tggggctgaa ctggtgaagc ctgggtcctc agtgaaaatt       60

tcctgcaagg cttctggcta caccttcacc agtaacttta tgcactggat aaaacagcag      120

cctggaaatg gccttgagtg gattgggtgg atttatcctg gagatggtga tacagattac      180

aatcaaaagt tcattgggaa ggcaacactc actgcagaca aatcctccag cacagcctat      240

atgcagctca gcagcctgac atctgaggac tctgcagtct atttctgttc aagatcgaat      300

tcgggataca attggtttgc ttactggggc caaggcactc tggtcaccgt ctcctca         357


<210>  13
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  13

Gly Tyr Thr Phe Thr Ser Asn Phe 
1               5               


<210>  14
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  14

Ile Tyr Pro Gly Asp Gly Asp Thr 
1               5               


<210>  15
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  15

Ser Arg Ser Asn Ser Gly Tyr Asn Trp Phe Ala Tyr 
1               5                   10          


<210>  16
<211>  107
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  16

Asp Ile Val Leu Thr Gln Ser Pro Pro Val Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Leu Ser Cys Lys Ala Ser Gln Asn Ile Asn Lys Asn 
            20                  25                  30          


Leu Asp Trp Tyr Gln Gln Lys His Gly Glu Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Tyr Thr Asn Asn Leu Gln Thr Gly Ile Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Tyr Thr Leu Thr Ile Arg Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Tyr Gln Tyr Arg Thr Gly Trp Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Glu Leu Lys Arg 
            100                 105         


<210>  17
<211>  321
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  17
gacattgtgc tcacccagtc tcctccagtc ctgtctgcat ctgtgggaga cagagtcact       60

ctcagctgca aagcaagtca gaatattaat aagaacttag actggtatca acaaaagcat      120

ggagaagctc caaaactcct gatatattat acaaacaatt tgcaaacggg tatcccatca      180

aggttcagtg gcagtggatc tggtacagat tacacactca ccatcagaag cctgcagcct      240

gaggatgttg ccacatatta ctgctatcag tatagaactg ggtggacctt cggtggaggc      300

accaagctgg agttgaaacg g                                                321


<210>  18
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  18

Gln Asn Ile Asn Lys Asn 
1               5       


<210>  19
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Tyr Thr Asn 
1           


<210>  20
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Tyr Gln Tyr Arg Thr Gly Trp Thr 
1               5               


